International Stem Cell (OTCMKTS:ISCO) Share Price Crosses Above Two Hundred Day Moving Average – What’s Next?

International Stem Cell Corp. (OTCMKTS:ISCO) crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $0.17 and traded as high as $0.2999. International Stem Cell shares last traded at $0.2999, with a volume of 7,300 shares changing hands.

International Stem Cell Trading Up 20.0%

The firm’s fifty day moving average price is $0.20 and its 200-day moving average price is $0.17. The company has a market cap of $2.40 million, a price-to-earnings ratio of -5.00 and a beta of -0.03.

International Stem Cell (OTCMKTS:ISCO) last posted its earnings results on Thursday, May 14th. The biotechnology company reported ($0.03) earnings per share (EPS) for the quarter. The business had revenue of $2.32 million during the quarter.

About International Stem Cell

International Stem Cell Corporation (OTCMKTS:ISCO) is a biotechnology company focused on the development and commercialization of human parthenogenetic stem cells (hpSC) for therapeutic and research applications. Parthenogenetic stem cells are derived from unfertilized human eggs and offer a scalable, ethically noncontroversial source of pluripotent cells. ISCO’s proprietary hpSC lines can be directed to differentiate into a wide variety of cell types, enabling preclinical programs in areas such as neurodegenerative disease, liver disease, diabetes and corneal regeneration.

In addition to its therapeutic pipeline, International Stem Cell maintains a research products division that supplies hpSC lines, differentiated cell populations and media formulations to academic institutions, biotechnology companies and contract research organizations.